tgAAV-CFTR: TGEN began a double-blind Phase II trial

Targeted Genetics Corp. (TGEN), Seattle, Wash.
Product: tgAAV-

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE